We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group | AQSE:AMS.GB | Aquis Stock Exchange | Ordinary Share | GB0004536594 | Ordinary Shares 5p |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 2.44% | 210.00 | 205.00 | 215.00 | 213.165 | 205.00 | 205.00 | 681 | 16:29:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAMS TIDMAV.
RNS Number : 1236O
Advanced Medical Solutions Grp PLC
02 November 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ----------------------------------------------------------------------------------------------------------- 1. Identity of the issuer or Advanced Medical Solutions the underlying issuer Group plc of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------------- ---------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights --------------------------------------------------------------------------------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached --------------------------------------------------------------------------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments --------------------------------------------------------------------------------------------------------- An event changing the breakdown of voting rights --------------------------------------------------------------------------------------------------------- Other (please CHANGE TO THE NUMBER OF VOTING RIGHTS specify): IN ISSUE ----------------------------------------------------------- -------------------------------------------- 3. Full name of person(s) Aviva plc & its subsidiaries subject to the notification obligation: (iii) ------------------------------------------------------------- -------------------------------------------- 4. Full name of shareholder(s) Registered Holder: (if different from 3.):(iv) BNY Norwich Union Nominees Limited 447,817* Chase (GA Group) Nominees Limited 7,082,143* Chase Nominees Limited 162,670* Available on Request 34,875* * denotes direct interest ------------------------------------------------------------- -------------------------------------------- 5. Date of the transaction 31 October 2016 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------------- -------------------------------------------- 6. Date on which issuer 01 November 2016 notified: ------------------------------------------------------------- -------------------------------------------- 7. Threshold(s) that is/are 4% to 3% Change at Direct crossed or Interest Level (Box 8A + 8B) reached: (vi, vii) ------------------------------------------------------------- -------------------------------------------- 8. Notified details: -------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) -------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE --------------- --------------------------- ---------------------------------------------------------------- Number Number Number Number of voting % of voting of of of shares rights rights (x) Shares Voting Rights --------------- -------------- ----------- ----------- -------------------------- ----------------------- Direct Direct Indirect Direct Indirect (xi) (xii) --------------- -------------- ----------- ----------- ---------- -------------- ------- -------------- Ordinary Shares Not Not GB0004536594 8,460,451* 8,460,451* 7,727,505 7,727,505 Disclosable 3.672% Disclosable -------------- ----------- ----------- ---------- -------------- ------- -------------- * Includes Right to Recall Loaned Shares (1,769,027) -------------------------------------------------------------------------------------------------------------- B: Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. --------------- -------------- ------------------------ -------------------------- ----------------------- RIGHT TO 689,263* RECALL LOANED SHARES N/A N/A *Direct Interest 0.327% --------------- -------------- ------------------------ -------------------------- ----------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights (xix, (xvii) period refers to xx) (xviii) ------------------ --------- ----------- ------------ ------------------- ---------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 8,416,768 3.999% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------- The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Friends Provident International Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Life Holdings UK Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Friends Life FPG Limited (wholly owned subsidiary of Aviva Life Holdings UK Limited) * Friends Life FPL Limited (wholly owned subsidiary of Friends Life FPG Limited) * Friends Life Limited (wholly owned subsidiary of Friends Life FPL Limited) * Friends Life and Pensions Limited (wholly owned subsidiary of Friends Life Limited) * Friends Provident International Limited (wholly owned subsidiary of Friends Life and Pensions Limited) --------------------------------------------------------------- Proxy Voting: -------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4 ------------------------------------- ---------------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------- ---------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------- ---------------------------------- 13. Additional information: Figures are based on a total number of voting rights of 210,453,923 as per the Company's Total Voting Rights Announcement of 31 October 2016. ------------------------------------- ---------------------------------- 14. Contact name: Neil Whittaker, Aviva plc ------------------------------------- ---------------------------------- 15. Contact telephone number: 01603 684420 ------------------------------------- ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUUVWRNSAARRA
(END) Dow Jones Newswires
November 02, 2016 04:58 ET (08:58 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions